Research Tracker›Biomarker Atlas›Marker Pages›Serum CXCL13 (PTLDS research)

Serum CXCL13 (PTLDS research): biomarker evidence

Serum CXCL13 (PTLDS research) appears in 1 entry of the OSMF biomarker atlas, covering Lyme Disease. Across those entries it is mixed in 1. It is currently reported in a single condition in this atlas; cross-condition comparison will be added as the dataset grows. Each row below links to a page with the comparison group, associated symptoms, test details and primary citation.

Lyme Disease

Where Serum CXCL13 (PTLDS research) is reported

Also listed as: B-cell chemokine

ConditionDirectionCompared againstAssociated symptomsSource
Lyme Disease↕ inconsistenthealthy controls, treated LymePersistent symptoms researchAucott et al. 2014

Frequently asked questions

In which conditions is Serum CXCL13 (PTLDS research) altered?

In the OSMF atlas Serum CXCL13 (PTLDS research) is reported in Lyme Disease. It is mixed in 1 across 1 entries.

Is there a standard clinical test for Serum CXCL13 (PTLDS research)?

The atlas entries for Serum CXCL13 (PTLDS research) do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.

Is one abnormal Serum CXCL13 (PTLDS research) result diagnostic?

No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.

Cite this page

Open Source Medicine Foundation. (2026). Serum CXCL13 (PTLDS research) across conditions: biomarker evidence. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/markers/serum-cxcl13-ptlds-research.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas

Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.